Gesellschaftsrecht / M&A

Finanzierungen und Anlageprodukte

Steuern

Regulierung

Homburger News

Homburger and TowerBrook Capital Partners

Homburger advised TowerBrook Capital Partners, a London and New York-based investment company, on its acquisition of a majority stake of the IDAK Food Group. The management team of IDAK Food Group retains a minority stake. IDAK Food Group is a strongly networked group of specialized companies and manufacturers in the premium frozen food sector.
The Homburger team was led by Anna Peter (Corporate / M&amp;A) and Jürg Frick (Financing and Investment Products) and included Héloïse de Jamblinne, Alessandra Dumitru and Carolina Rodriguez (all Corporate / M&amp;A), Nathalie Scherrer (Financing and Investment Products), Reto Heuberger and Juliette Buob (all Tax) as well as Richard Stäuber, Andreas Burger and Christoph Grüninger (all Regulatory).

Homburger advised TowerBrook Capital Partners on its acquisition of IDAK Food Group

Dali Discount AG_web_640x140

DALI DISCOUNT AG

Swiss-based DALI DISCOUNT AG, a leading hard discounter in Southeast Asia, has received multiple equity financings as part of its Series C financing round and its previous financing round from Navegar, Creador, Venturi Partners, the Asian Development Bank, DEG – Deutsche Investitions- und Entwicklungsgesellschaft and other institutional investors.
DALI DISCOUNT operates the first and fastest-growing hard discounter in Southeast Asia and provides quality everyday goods at low prices in its stores.
The Homburger team comprises Andreas Müller, Oliver Kneubühl, Carlo Sulser, Oriana Schöni and Carolina Rodriguez (all Corporate / M&amp;A) and Stefan Oesterhelt and Laetitia Fracheboud (both Tax).

Homburger advises DALI DISCOUNT AG in connection with its Series C financing round and its previous financing round

Kapitalmarkt

IP / IT

Datenschutz

Arbeitsrecht und Vergütung für Führungskräfte

Wettbewerb

Healthcare / Life Sciences

Vectivio

Homburger and VectivBio

On May 22, 2023, VectivBio Holding AG (Nasdaq: VECT), Basel (Switzerland), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare gastrointestinal conditions, and Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, announced that they had entered into an agreement for Ironwood to launch an all-cash public tender offer to acquire all outstanding shares in VectivBio for USD 17 per share, with an estimated aggregate consideration of approximately USD 1 bn, net of VectivBio cash and debt. The acquisition price represents a premium of 80% relative to the volume-weighted average share price over the previous 90 trading days. The offer is subject to customary conditions and expected to close in mid-2023. VectivBio&#8217;s board of directors unanimously recommends the offer. Orbimed, Forbion and Versant Ventures, and VectivBio&#8217;s directors and officers jointly representing 28.6% of VectivBio&#8217;s shareholdings, entered into tender and support agreements in connection with, and in support of, the offer.
Homburger AG serves as legal and tax advisor to VectivBio on the transaction. The Homburger team includes Andreas Müller, Margrit Marti, Oliver Kneubühl, Francesco Bernasconi, Oliver Dalla Palma, Daniel Wenzinger and Carolina Rodriguez (all Corporate / M&amp;A), Lorenzo Togni (Capital Markets), Stefan Oesterhelt, Philippe Gobet and Kevin Müller (all Tax), Stefan Bindschedler (Financing and Investment Products), Luca Dal Molin (IP / IT; Data Protection), Angela Casey (Employment and Executive Compensation), and Richard Stäuber and Christoph Grüninger (Competition, Regulatory).

Homburger advises VectivBio with respect to the announced public cash tender offer from Ironwood Pharmaceuticals

Carolina
Rodríguez

Homburger advised TowerBrook Capital Partners on its acquisition of IDAK Food Group

Homburger advises DALI DISCOUNT AG in connection with its Series C financing round and its previous financing round

Homburger advises VectivBio with respect to the announced public cash tender offer from Ironwood Pharmaceuticals

Join the Team

Carolina Rodríguez

Karriere

Sprachen

Teams

CarolinaRodríguez

Homburger advised TowerBrook Capital Partners on its acquisition of IDAK Food Group

Homburger advises DALI DISCOUNT AG in connection with its Series C financing round and its previous financing round

Homburger advises VectivBio with respect to the announced public cash tender offer from Ironwood Pharmaceuticals

Join the Team

Carolina Rodríguez

Karriere

Sprachen

Teams

Carolina
Rodríguez